Bruker (BRKR) Reports In-Line Q3 EPS ; Offers Guidance
Tweet
Share
E-mailGet Alerts BRKR Hot Sheet
Price: $59.56 -0.6%
Financial Fact:
Cost of product revenue: 172.2M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Cost of product revenue: 172.2M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Bruker (NASDAQ: BRKR) reported Q3 EPS of $0.60, in-line with the analyst estimate of $0.60. Revenue for the quarter came in at $864.4 million versus the consensus estimate of $866.46 million.
GUIDANCE:
Bruker sees FY2024 EPS of $2.36-$2.41, versus the consensus of $2.60. Bruker sees FY2024 revenue of $3.34-3.37 billion, versus the consensus of $3.4 billion.
For earnings history and earnings-related data on Bruker (BRKR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA maintains underperform ratings on six BDC stocks
- Boeing workers reject contract, authorize strike
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
